Call to bioscientists: choose and use your chemicaI probes very carefully 10 Jul 2017 ICR Chief Executive Paul Workman blogs about a new article we have published in Cancer Cell that seeks to draw to the attention of the bioscience community the serious dangers of using flawed chemical probes – or tool compounds – in mechanistic investigations and target validation for translational research. Find out more Show/Hide
NCRI 2016: Five reasons why we must prioritise innovative drug discovery to tackle cancer’s challenges 07 Nov 2016 ICR Chief Executive Professor Paul Workman took part in a debate at the NCRI conference on how to prioritise research spending — on creating new treatments or repurposing old ones. Here he outlines the arguments in favour of innovation. Find out more Show/Hide